Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli. - Wikidata - awgldk - TriplyDB

Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli.

Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli.

http://www.wikidata.org/entity/Q38484046

about

Combating antimicrobial resistance: policy recommendations to save lives Patient's origin and lifestyle associated with CTX-M-producing Escherichia coli: a case-control-control study.Bacteremia caused by extended-spectrum-β-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality.Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15.Risk Factors for and Outcomes of Bacteremia Caused by Extended-Spectrum ß-Lactamase-Producing Escherichia coli and Klebsiella Species at a Canadian Tertiary Care Hospital.Epidemiology and risk factors of community onset infections caused by extended-spectrum β-lactamase-producing Escherichia coli strains.Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli over a 6-year period.Antimicrobial resistance in Asia: current epidemiology and clinical implications Community-Onset Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Invasive Infections in Children in a University Hospital in France.Risk factors and molecular epidemiology of community-onset, multidrug resistance extended-spectrum β-lactamase-producing Escherichia coli infections Predictors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli infection in a Midwestern community Third-generation cephalosporin resistance of community-onset Escherichia coli and Klebsiella pneumoniae bacteremia in a secondary hospital.Mortality associated with community-acquired cephalosporin-resistant Escherichia coli in patients admitted to a district hospital in a resource-limited setting.Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis.Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections.Risk factors of organ failure in patients with bacteremic cholangitis.Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases).Impact of appropriateness of empiric therapy on outcomes in community-onset bacteremia by extended-spectrum-β-lactamase producing Escherichia coli and Klebisella pneumoniae definitively treated with carbapenems.Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremia.Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.Risk factors for mortality and impact of broad-spectrum cephalosporin resistance on outcome in bacteraemic intra-abdominal infections caused by Gram-negative bacilli.Predictive factors of bacteremia in patients with febrile urinary tract infection: an experience at a tertiary care center.High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China.Risk factors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli bacteremia.Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli, with a special emphasis on antimicrobial therapy.Third-generation cephalosporin resistance in gram-negative bacteria in the community: a growing public health concern.Clinical characteristics of community-acquired acute pyelonephritis caused by ESBL-producing pathogens in South Korea.Clinical implications of healthcare-associated infection in patients with community-onset acute pyelonephritis.Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).Phenotypic and genotypic characterizations of extended-spectrum beta-lactamase-producing Escherichia coli in Thailand

P2860

Q24632857-3545983A-7262-4AD8-A009-1F15CC3E963B Q31047716-59D16FCF-3E15-4672-81F9-10661722ADEF Q34085171-ADF7C7BA-E2B2-4EC0-AC70-2C6237DBE543 Q34315040-B7F316CA-0692-4B08-A004-3C0FF30792C0 Q35551647-FBD7D8B9-C85D-43BA-9136-D00C6A4E07BB Q35689050-E4615EA7-81D7-4701-A47F-6DD33455334A Q36461110-4E598E30-6421-430A-8CFC-FAB721D58581 Q37001723-B3DCF081-416C-4027-B3FF-7B502358AC49 Q37192102-C2085CB7-D613-4A66-858D-6CC9F24E351D Q37205420-FC0128F9-C8D6-4140-BB52-12913520B7E9 Q37559129-D3B0676C-1083-4AA5-96B6-89B36705065B Q37562416-591A59C4-913C-4C46-AF38-703F9BB22E9A Q37598820-3FBC34D2-8BE4-4E07-9E44-101D0AE8101A Q37694277-1A98D4DA-A615-481B-92BB-48E9525FEB9C Q37991287-251C9663-074C-499C-BBE0-2E3801CD1084 Q38048860-590EB1E4-6185-48A4-8052-81F1D4C677B3 Q38062337-BCBD5C54-4002-40C3-AE8E-88656511EB0D Q38074212-40637FCB-D457-4A4C-9E28-94BAAB5DA9EC Q38401630-83A3F1A1-4AE0-4E11-942C-6367C7174F79 Q38467189-141C5EE4-46F0-4510-9AF0-C82E50AB87D5 Q38474339-E924227E-A0E4-4E55-8567-217A176B4845 Q38479035-AC660173-AD18-44E5-AD2E-8499DAE463B0 Q40212725-8E3B214D-E91C-4A83-A821-50F9F6D25957 Q40541461-7C5ACB85-0B03-48EF-A8CC-E897758DFC31 Q41948199-7E775C85-463C-4093-AC76-9F9D9E286585 Q42270339-00F2A10F-1C05-4788-92B6-77796DC3CB49 Q42433179-B7DD2875-2985-4BF2-B533-28B0B400204B Q54315149-4AF1CE04-765C-4032-B309-5A4B2E325CA1 Q54364286-CCB6DCA6-EFFD-411E-9F38-3E023380FAEF Q55444694-070DEB42-6CB8-4BAF-ADFA-BF955CB7B892 Q59125762-75D1B1B6-4EFA-4B6E-B63C-FBF0D41D317E

P2860

Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli.

http://www.wikidata.org/entity/Q38484046

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Risk factors and treatment out ...... se-producing Escherichia coli.

@en

type

label

Risk factors and treatment out ...... se-producing Escherichia coli.

@en

prefLabel

Risk factors and treatment out ...... se-producing Escherichia coli.

@en

P1433

Q38484046-16F80435-CCB7-4B2F-8A07-C7D657D82B49

P1476

Q38484046-1DB15C4B-D4D0-4ED8-A24A-C9612D3B57C5

P2093

Q38484046-1256D504-C1B5-48F3-B42A-2D95B057E044

Q38484046-1319EF01-A7E4-4A92-A320-5CD8A2DB465A

Q38484046-2B232D27-9CAB-49A2-9A7C-7CDD209D57CA

Q38484046-2CB19E53-75D2-488D-8F97-41B5A83818A9

Q38484046-3D78AA16-5B3F-4ECC-990A-B2C4C0753E97

Q38484046-5CC51B67-AE0C-4DF7-AF45-ED91A10F774A

Q38484046-674ABDE5-F111-4813-982D-6BF11EDC88B5

Q38484046-6A9A286A-293D-41EE-8B83-8F41BE61A020

Q38484046-980C4825-B46A-4EC7-8B8B-3C13A9BCC258

Q38484046-AAC5654E-F64D-478C-91F4-63F44B18BB86

P304

Q38484046-B06C29E9-A49F-45C5-994E-F24D83DCE836

P31

Q38484046-0DB213F5-828D-4B6C-8AE7-B29D22C2A081

P356

Q38484046-23847FC9-64CF-42C6-91D2-390F727C0909

P433

Q38484046-6C5CD859-3F6D-492E-81FF-2AE15E27FDA9

P478

Q38484046-3AEE1659-8177-4DA0-BA30-7656CB333742

P50

Q38484046-1B3CDBA5-17FC-4903-93C8-91DDC7B43785

Q38484046-46CB989E-2F5D-4588-9A9B-4EF3E3BB0B1A

Q38484046-485E0764-24BA-4CF9-8F15-22C5BFFFD0DA

Q38484046-7F8046D7-5B4B-43A0-94BA-D58D25F3D42E

Q38484046-D2810751-9BA5-4AEF-8098-9DFA2C1E69BB

Q38484046-E5B2AF20-8542-4D3B-AD10-A779AFF72A35

P577

Q38484046-A43C6F10-5EA6-4FB9-AC64-DE47D0B527B3

P5875

Q38484046-6259F947-16B3-497D-BC1D-DF893B567A3A

P698

Q38484046-A8AFB664-FF08-464A-8520-AC6C7582E12C

P356

J.IJANTIMICAG.2010.05.009

P1433

International Journal of Antimicrobial Agents

P1476

Risk factors and treatment out ...... se-producing Escherichia coli.

@en

P2093

Cheol-In Kang

http://www.w3.org/2001/XMLSchema#string

Chisook Moon

http://www.w3.org/2001/XMLSchema#string

Doo Ryeon Chung

http://www.w3.org/2001/XMLSchema#string

Hyuck Lee

http://www.w3.org/2001/XMLSchema#string

Hyun Kyun Ki

http://www.w3.org/2001/XMLSchema#string

Hyun-Ha Chang

http://www.w3.org/2001/XMLSchema#string

Jae-Hoon Song

http://www.w3.org/2001/XMLSchema#string

Ki Tae Kwon

http://www.w3.org/2001/XMLSchema#string

Korean Network for Study of Infectious Diseases (KONSID)

http://www.w3.org/2001/XMLSchema#string

Sang Yop Shin

http://www.w3.org/2001/XMLSchema#string

P304

284-287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJANTIMICAG.2010.05.009

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44802457

http://www.w3.org/2001/XMLSchema#string

P698

20580534

http://www.w3.org/2001/XMLSchema#string